Guangzhou Innogen Pharmaceutical Group Co., Ltd (HKG:2591)
Hong Kong · Delayed Price · Currency is HKD 7.26
+0.15 (2.11%)
Jul 31, 2026, 4:08 PM HKT
HKG:2591 Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, HKG:2591 stock has a consensus rating of "Strong Buy" and an average price target of $31.45. The average 1-year stock price forecast is 333.20% higher than the current stock price, while the lowest is $28.30 (+289.81%) and the highest is $34.61 (+376.72%).
Price Target: $31.45 (+333.20%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Jun 27, 2026.
Analyst Ratings
The average analyst rating for HKG:2591 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Guotai Haitong No rating | Guotai Haitong | Buy Maintains $16.70 | Buy | Maintains | $16.70 | +130.03% | Jun 27, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains $28.10 | Buy | Maintains | $28.10 | +287.05% | Apr 10, 2026 |
Financial Forecast
Revenue This Year
429.03M
from 131.51M
Increased by 226.24%
Revenue Next Year
1.03B
from 429.03M
Increased by 138.96%
EPS This Year
-0.41
from -0.79
EPS Next Year
0.13
from -0.41
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.